BTM-3566

DRUG2 trials

Sponsors

Bantam Pharmaceuticals

Conditions

Advanced Solid TumorsLymphoma, B-Cell

Phase 1

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

RecruitingNCT06792734

Bantam PharmaceuticalsLymphoma, B-Cell

Start: 2025-02-14End: 2027-12-01Target: 24Updated: 2026-07-07

BTM-3566 in Advanced Solid Tumors

RecruitingNCT07266285

Bantam PharmaceuticalsAdvanced Solid Tumors

Start: 2025-12-10End: 2027-08-31Target: 30Updated: 2025-12-17

Related Papers

A phase 1 trial of BTM-3566 in relapsed/refractory mature B cell lymphomas.

Journal of Clinical Oncology2025-05-28